Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

ClinicalTrials.gov ID: NCT01981473

Public ClinicalTrials.gov record NCT01981473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 1:10 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to examine the relationship between anti-drug antibodies, serum drug concentrations, and clinical response for rheumatoid arthritis patients being treated with etanercept, adalimumab or infliximab.

Study identification

NCT ID
NCT01981473
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Pfizer
Industry
Enrollment
605 participants

Conditions and interventions

Interventions

Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2014 (Type not available)
Primary completion
Dec 2014 (Actual)
Completion
Dec 2014 (Actual)
Last update posted
Jan 12, 2016

2014

United States locations

U.S. sites
34
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Glendale Arizona 85304 —
Arizona Arthritis & Rheumatology Associates, P. C. Mesa Arizona 85202 —
Arizona Arthritis & Rheumatology Phoenix Arizona 85032 —
Arizona Arthritis and Rheumatology Research, PLLC Phoenix Arizona 85032 —
Arizona Arthritis & Rheumatology Research Sun City Arizona 85351 —
Mercy Clinic Hot Springs Communities Hot Springs Arkansas 71913 —
Sutter Institute for Medical Research Sacramento California 95816 —
Arthritis Care Center, Incorporated San Jose California 95035 —
Rheumatology Consultants of Delaware dba Delaware Arthritis Lewes Delaware 19958 —
Omega Research Consultants, LLC DeBary Florida 32713 —
Center for Rheumatology, Immunology, and Arthritis Fort Lauderdale Florida 33309 —
Florida Medical Research Gainesville Florida 32607 —
Arthritis and Rheumatic Care Center South Miami Florida 33143 —
Health Point Medical Group, Inc. Tampa Florida 33614 —
Northeast Georgia Diagnostic Clinic, LLC Gainesville Georgia 30501 —
Via Christi Hospitals Wichita, Inc. Wichita Kansas 67214 —
Rheumatology Associates of Baltimore Baltimore Maryland 21286 —
Phase III Clinical Research Fall River Massachusetts 02720 —
David S. Rosenberg, M.D Florissant Missouri 63031 —
Dr Melvin Albert Churchill Jr Lincoln Nebraska 68516 —
Prospect Medical Offices Midland Park New Jersey 07432 —
Advanced Arthritis Care Center Brooklyn New York 11235 —
Prem C.Chatpar, M.D., LLC Plainview New York 11803 —
Box Arthritis and Rheumatology Charlotte North Carolina 28210 —
Clinical Research Center of Reading, LLC Wyomissing Pennsylvania 19610 —
Low Country Rheumatology, PA North Charleston South Carolina 29406 —
Comprehensive Rheumatology Care Hendersonville Tennessee 37075 —
Elizabeth Marini Simpson Hixon Tennessee 37343 —
Austin Regional Clinic Austin Texas 78731 —
Accurate Clinical Research Houston Texas 77084 —
Clinical Research Institute of Houston Houston Texas 77090 —
Spring Clinical Research Tomball Texas 77375 —
Center for Arthritis and Rheumatic Diseases, P.C. Chesapeake Virginia 23320 —
Arthritis Northwest, PLLC Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01981473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2016 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01981473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →